EBS icon

Emergent Biosolutions
EBS

Overview Fund Trends Analyst Outlook Journalist POV
12.48 USD
--0.36
2.8%
At close Updated Oct 31, 4:00 PM EDT
Pre-market
After hours
12.19
--0.29
2.32%
1 day
-2.8%
5 days
25.93%
1 month
41.5%
3 months
112.24%
6 months
133.71%
Year to date
21.52%
1 year
37.75%
5 years
-86.3%
10 years
-62.41%
 

About: Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Employees: 900

Healthcare Drug Manufacturers - Specialty & Generic
0
Funds holding %
of 7,505 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 6 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™